Literature DB >> 30122459

Natural killer cells in inflammation and autoimmunity.

Beatrice Zitti1, Yenan T Bryceson2.   

Abstract

First described 40 years ago, natural killer (NK) cells represent the founding members of the innate lymphoid cell (ILC) family. They were initially defined by their ability to kill cancer cells of hematopoietic origin. More recently, NK cells are recognized not only for their ability to kill infected or malignant cells, but also for mediating cytotoxicity against a range of normal immune cells. They thereby play an important physiological role in controlling immune responses and maintaining homeostasis. Besides cytotoxic activity, NK cells activation is accompanied by secretion of pro-inflammatory cytokines. Hence, NK cells have the potential to act both in driving inflammation and in restricting adaptive immune responses that may otherwise lead to excessive inflammation or even autoimmunity. Here, we highlight how NK cell activity is linked to inflammasome activation and review new molecular insights to the roles of NK cells in inflammation and autoimmunity. Furthermore, in light of new insights to NK cell differentiation and memory, we deliberate on how distinct NK cell subsets may impact immunoregulatory functions. Hypothetically, memory-like or adaptive NK cells could drive NK cell-mediated autoreactive diseases. Together, new findings underscore the complex yet important physiological roles of NK cells in both promoting inflammation and exerting immunoregulation and maintenance of immune homeostasis. Insights raise intriguing questions as to how NK cells themselves maintain self-tolerance.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Adaptive NK cells; Autoimmunity; Immunoregulation; Inflammation; NK cells; Self-tolerance

Mesh:

Substances:

Year:  2018        PMID: 30122459     DOI: 10.1016/j.cytogfr.2018.08.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  40 in total

Review 1.  Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation.

Authors:  Shabnam Shalapour; Michael Karin
Journal:  Immunity       Date:  2019-07-16       Impact factor: 31.745

2.  Pathological Role of Natural Killer Cells in Parkinson's Disease: A Systematic Review.

Authors:  Le Zhang; Yingshuang Zhang; Dongsheng Fan
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

Review 3.  N-Glycosylation and Inflammation; the Not-So-Sweet Relation.

Authors:  Barbara Radovani; Ivan Gudelj
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 4.  Spotlight on TAP and its vital role in antigen presentation and cross-presentation.

Authors:  Ian Mantel; Barzan A Sadiq; J Magarian Blander
Journal:  Mol Immunol       Date:  2021-12-29       Impact factor: 4.174

Review 5.  Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders.

Authors:  Nicholas A Maskalenko; Dmitry Zhigarev; Kerry S Campbell
Journal:  Nat Rev Drug Discov       Date:  2022-03-21       Impact factor: 112.288

6.  Immunomodulatory effects of a new whole ingredients extract from Astragalus: a combined evaluation on chemistry and pharmacology.

Authors:  Zhi Xin Li; Guan Ding Zhao; Wei Xiong; Ke Gang Linghu; Qiu Shuo Ma; Wai San Cheang; Hua Yu; Yitao Wang
Journal:  Chin Med       Date:  2019-03-27       Impact factor: 5.455

7.  Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness.

Authors:  Filip Segerberg; Christian Lundtoft; Sarah Reid; Karin Hjorton; Dag Leonard; Gunnel Nordmark; Mattias Carlsten; Niklas Hagberg
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

8.  Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy.

Authors:  Bin Liu; Wen Cao; Jin Cheng; Sisi Fan; Shaojun Pan; Lirui Wang; Jiaqi Niu; Yunxiang Pan; Yanlei Liu; Xiyang Sun; Lijun Ma; Jie Song; Jian Ni; Daxiang Cui
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

9.  High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.

Authors:  Sarah M McAlpine; Sarah E Roberts; John J Heath; Fabian Käsermann; Andrew C Issekutz; Thomas B Issekutz; Beata Derfalvi
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

10.  NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS.

Authors:  Cynthia Louis; Fernando Souza-Fonseca-Guimaraes; Yuyan Yang; Damian D'Silva; Tobias Kratina; Laura Dagley; Soroor Hediyeh-Zadeh; Jai Rautela; Seth Lucian Masters; Melissa J Davis; Jeffrey J Babon; Bogoljub Ciric; Eric Vivier; Warren S Alexander; Nicholas D Huntington; Ian P Wicks
Journal:  J Exp Med       Date:  2020-05-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.